Filing Details

Accession Number:
0001209191-21-059996
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-07 20:04:44
Reporting Period:
2021-10-05
Accepted Time:
2021-10-07 20:04:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1426332 Ngm Biopharmaceuticals Inc NGM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1468482 D Hsiao Lieu 333 Oyster Point Boulevard
South San Francisco CA 94080
Svp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-05 2,000 $12.06 2,000 No 4 M Direct
Common Stock Disposition 2021-10-05 2,000 $22.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-10-05 2,000 $0.00 2,000 $12.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
190,000 2029-03-18 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2021.
  2. The shares subject to the stock option vest over a four-year period measured from the grant date, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.